A novel strategy for functional GPCR antagonism via bispecific antibody-mediated endocytosis and lysosomal degradation is reported via bispecific antibody-mediated endocytosis and lysosomal degradation, establishing induced endocytosis and rewiring protein trafficking as a new paradigm for therapeutic GPCR modulation.
Kaitlin Rhee, L. Shue, Akimasa Adachi et al.· Nature· 2 citations
ABSTRACT Metabolic reprogramming is a hallmark of gastric cancer (GC); however, the role of transcriptional regulators in modulating glycolysis remains incompletely understood. By integrating proteomic, transcriptomic, and CRISPR‐based functional screening datasets, we identified WDR12, a WD40‐family protein that is up...
Ru-Tong Zhang, De-Hua Liu, Xiao-Xi Feng et al.· Cancer Science· 0 citations
Proteomic analysis of BN-PAGE fractions shows that assembly of the mitochondrial respiratory supercomplexes is markedly enhanced during mitosis in HeLa and MDA-MB-468 cancer cells, and reveals supercomplex assembly as a key mechanism coordinating mitochondrial fission with metabolic adaptation to support cell division...
Ting Wang, Ao-Xing Cheng, Ling-Yu Kong et al.· EMBO Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.